These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 17379001)

  • 1. Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients with end-stage renal disease.
    Hirano T; Hayashi T; Adachi M; Taira T; Hattori H
    Metabolism; 2007 Apr; 56(4):462-3. PubMed ID: 17379001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease.
    Sakurai T; Oka T; Hasegawa H; Igaki N; Miki S; Goto T
    Nephron; 1992; 61(4):409-14. PubMed ID: 1501737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease.
    Hayashi T; Hirano T; Taira T; Tokuno A; Mori Y; Koba S; Adachi M
    Atherosclerosis; 2008 Mar; 197(1):154-8. PubMed ID: 17462654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII.
    Hirano T; Sakaue T; Misaki A; Murayama S; Takahashi T; Okada K; Takeuchi H; Yoshino G; Adachi M
    Kidney Int; 2003 Jun; 63(6):2171-7. PubMed ID: 12753304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients.
    Tonbul HZ; Turkmen K; Kayıkcıoglu H; Ozbek O; Kayrak M; Biyik Z
    Ren Fail; 2011; 33(8):770-5. PubMed ID: 21770856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of end-stage renal failure on concentrations of free apolipoprotein A-1 in serum.
    Duval F; Frommherz K; Atger V; Drüeke T; Lacour B
    Clin Chem; 1989 Jun; 35(6):963-6. PubMed ID: 2499432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
    Ribeiro S; Faria Mdo S; Silva G; Nascimento H; Rocha-Pereira P; Miranda V; Vieira E; Santos R; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
    Hemodial Int; 2012 Oct; 16(4):481-90. PubMed ID: 22515595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
    Tovbin D; Schnaider A; Vorobiov M; Rogachev B; Basok A; Shull P; Novack V; Friger M; Avramov D; Zlotnik M
    J Nephrol; 2005; 18(2):174-80. PubMed ID: 15931645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations.
    Sun Z; Larson IA; Ordovas JM; Barnard JR; Schaefer EJ
    Atherosclerosis; 2000 Aug; 151(2):381-8. PubMed ID: 10924714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients.
    Pruneta-Deloche V; Ponsin G; Groisne L; Fruchart-Najib J; Lagarde M; Moulin P
    Atherosclerosis; 2005 Aug; 181(2):403-5. PubMed ID: 16039297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus.
    Karakitsos D; De Groot E; Patrianakos AP; Parthenakis F; Boletis J; Karabinis A; Kyriazis J; Vardas P; Daphnis E
    Am J Nephrol; 2006; 26(4):340-7. PubMed ID: 16825760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.